LifeSci Venture Partners is an early-stage investment firm focused on life sciences and healthcare. Formed in 2017, the firm typically invests in Series A and B rounds, with occasional participation in later stages. Their portfolio spans a range of therapeutic areas and medical technologies, reflecting a broad interest in innovative healthcare solutions.
Notable portfolio companies include Caribou Biosciences, eGenesis, and Moma Therapeutics. As part of LifeSci Partners, a life sciences and healthcare consultancy, the firm leverages deep scientific expertise to drive long-term conviction and support through company building, private financing, and public markets. Their collaborative approach aims to accelerate medical breakthroughs and support emerging biopharma companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.